These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10703829)

  • 61. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
    Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 63. The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors.
    Strand V; Hochberg MC
    Arthritis Rheum; 2002 Aug; 47(4):349-55. PubMed ID: 12209478
    [No Abstract]   [Full Text] [Related]  

  • 64. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 65. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 66. The renal response to an acute protein load in man: clinical perspective.
    Rodríguez-Iturbe B
    Nephrol Dial Transplant; 1990; 5(1):1-9. PubMed ID: 2109280
    [No Abstract]   [Full Text] [Related]  

  • 67. Pro: dopamine and renal preservation.
    Hines R
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):333-4. PubMed ID: 7669969
    [No Abstract]   [Full Text] [Related]  

  • 68. Renal side-effects of cyclo-oxygenase-type-2 inhibitor use.
    Stubanus M; Riegger GA; Kammerl MC; Fischereder M; Krämer BK
    Lancet; 2000 Feb; 355(9205):753. PubMed ID: 10703829
    [No Abstract]   [Full Text] [Related]  

  • 69. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
    LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
    Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can the effects of protein restriction on the progression of renal failure also be achieved by pharmacological means?
    Verberckmoes R; Van Renterghem Y
    Blood Purif; 1989; 7(1):58-60. PubMed ID: 2493259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects].
    Burdan F; Korobowicz A
    Pol Merkur Lekarski; 2003 Apr; 14(82):352-5. PubMed ID: 12868201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonsteroidal antiinflammatory drugs and renal function.
    Dunn MJ
    Annu Rev Med; 1984; 35():411-28. PubMed ID: 6426373
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.